Event Organizers

The Bacteriophage Research and Therapy Society was founded in 2017 and registered on 19 December 2018. The society seeks to use bacteriophages to treat drug-resistant diseases and combat antimicrobial resistance (AMR). The association provides a forum for researchers to collaborate with phage scientists. The society aims to utilize national and international expertise and resources by gathering scientists, academicians, and clinicians pursuing basic and translational bacteriophage research. The society studies bacteriophages in rivers and sewage treatment, their use as antibacterial agents, vaccines, gene therapy, diagnostics, drug delivery, and more. Given the slow pace of infectious disease treatment discovery and the prevalence of AMR, it's time to study the problems of bacteriophages as therapies. To bridge the curriculum-practice gap for students and researchers, the society holds technical conferences, seminars, and workshops nationwide. Members receive Young Scientist honors, early career research honors, and Editorial team membership for their phage therapy research. Society created a scientific publication to improve research-based learning. Expert peer review ensures high-quality publications in the journal. International Journal of Bacteriophage Research is published annually in January. It publishes bacteriophage-related reviews, research papers, genetic engineering, in-vitro and invivo investigations, and molecular screening. 

The University of Madras is one of the first of the three Universities established in India in the year 1857 and has been marching in its 166th year of academic and research excellence. It is the mother of almost all the Universities in southern India and has stood out as a beacon of knowledge for generations. It has distinguished itself by preserving its ancient heritage and modern developments equally. The University of Madras has the distinction of producing 2 Nobel laureates, Sir C.V. Raman and Dr. S. Chandrasekhar for their epoch-making research and has given 5 presidents to our country namely Sarvepalli Radhakrishnan, V. V. Giri, Neelam Sanjeeva Reddy, R. Venkataraman and Dr. A.P.J. Abdul Kalam. 

The University Botany Laboratory (UBL) was established in 1930 and it received the CAS status from the UGC in 1964 and retained the status for the past 59 years. The CAS in Botany is well known for its pioneering research contribution on 4 major thrust areas recognized by the UGC such as Plant Pathology, Mycology, Algology, and Herbal Science. The research contributions made by eminent scholars like Professors M.O.P. Iyengar, T. S. Sadasivan, C.V. Subramanian, and T.V. Desikachary have taken the heights of the Centre to a greater height. CAS in Botany is fully equipped with all necessary laboratory and other infrastructure facilities. The center offers M.Sc., Botany, M.Phil., Botany and Ph.D. Botany degree courses. The Centre is currently being headed by Prof. N. Mathivanan.

The Bhabha Atomic Research Centre (BARC) is India's premier nuclear research facility, located in Trombay, Mumbai. Established in 1954. BARC is named after Dr. Homi J. Bhabha, a renowned Indian physicist and founding director of the center. BARC's primary mission is to conduct research and development in the field of nuclear science, engineering, and related areas, including advanced materials, radiation biology, and nuclear medicine. The center is also responsible for designing and building India's nuclear power reactors, as well as developing and producing radioisotopes. medical and industrial applications BARC has contributed immensely towards India’s nuclear program and development of allied technologies.

 The Water and Steam Chemistry Division of the Chemistry Group at BARC is actively working to reduce corrosion, activity buildup, and biofouling in operational nuclear reactors. One of the key missions of this group is to provide environmentally friendly alternatives for biofouling control. Furthermore, the group is engaged in developing numerous biofilm-based technologies for various social applications. The group is now working extensively on Bacteriophages for their application as an environmentally sustainable anti-biofouling agent through the targeted removal of organisms of interest from a complex community of fouling organisms. The group is also working towards building a "Phage bank" where fully characterized, ready-to-use bacteriophages will be stored for Phage therapy.